Clinical Trials in Los Angeles

Showing 16401-16420 of 16,901 trials

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

NCT00085891

The purpose of this study is to demonstrate superior efficacy of sustained release quetiapine compared to placebo in patients with schizophrenia after receiving treatment for up to 6 weeks.

Schizophrenia

AstraZeneca535 participantsStarted Jun 2004

Birmingham, Alabama, United States • Cerritos, California, United States • Los Angeles, California, United States +26 more locations

COMPLETEDPhase 1< 1 mile

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

NCT00064584

This is the first study of the drug CT53518 when given to humans. The purpose of this study is to determine the highest dose of CT53518 that can safely be given to patients with Acute Myelogenous Leukemia (AML) and to identify the side effects associated with taking the drug. The study will evaluate how CT53518 is absorbed, broken down, and eliminated by the body. Additionally, the study will evaluate the effects of the drug on a specific type of cell in bone marrow and blood, known as a blast.

Acute Myelogenous LeukemiaMyelodysplastic Syndrome

Millennium Pharmaceuticals, Inc.60 participantsStarted May 2002

Los Angeles, California, United States • Boston, Massachusetts, United States • New York, New York, United States +2 more locations

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

Find Trials by Condition in Los Angeles

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.

Obese Patients With Type 2 Diabetes

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

Lofexidine for Inpatient Opiate Detox

Efficacy of Levetiracetam in Essential Tremor

Predicitve Use of Spot Urine Protein/Creatinine Ratios in Preeclampsia

NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation